04/22/2024
11:15 PM | Tyra Biosciences (Filer)
| Form EFFECT | |
04/05/2024
3:20 PM | Tyra Biosciences (Filer)
| Form PRE 14A | |
03/19/2024
6:58 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:01 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:38 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:33 PM | Tyra Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/19/2024
3:35 PM | Tyra Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
03/13/2024
4:46 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:19 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
03/08/2024
4:38 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:40 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:58 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:00 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:24 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/09/2024
6:26 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/08/2024
4:10 PM | Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/08/2024
4:16 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:09 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:22 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:23 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
3:56 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024
3:40 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/05/2024
5:05 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
4:04 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
3:47 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
4:24 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
8:00 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:16 PM | Tyra Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023
3:50 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
6:27 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
6:36 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
6:37 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
4:30 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
4:34 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
4:38 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
4:41 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
7:52 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
6:35 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
5:41 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:31 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
 See why the elites are pouring billions into gold. |
06/28/2023
7:31 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:30 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
2:42 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
7:16 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:42 PM | Harris Irrevocable Trust 4 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:33 PM | Harris Irrevocable Trust 2 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:37 PM | Harris Irrevocable Trust 3 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:25 PM | Harris Irrevocable Trust 1 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
7:58 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
8:00 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | MORE ROBERT J (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Subramony Siddarth (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Simson Jake (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | CHEN ISAN (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Tyra Biosciences (Issuer)
Verjee Rehan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | KAPLAN GILLA (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
